Major DepressionNCT06614842
Common Factors Group Psychotherapy for General Mental Health Concerns
A study testing Common Factors Group Psychotherapy in people with Major Depression and Generalized Anxiety, run by University of Alabama at Birmingham.
Trial summary
The current research will investigate the impact of general psychotherapy using common factors (i.e., techniques and communication skills that are common to all major forms of psychotherapy) to investigate whether mental health professionals can treat a variety of mental health concerns utilizing this general form of… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Major Depression, Generalized Anxiety, Stress Disorder, Post Traumatic
- What is being tested?
- Common Factors Group Psychotherapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- 17 Jan 2025to 30 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- At least 18 years old
- Experiencing self-reported psychological distress
Who cannot join
- has engaged in self-harm within the last three months
- has attempted suicide within the last year
- has had an active plan to attempt suicide within the last 30 days
- currently diagnosed with any eating disorder
- has experienced hallucinations or delusions within the last 30 days
- has used narcotics within the last 7 days (heroin, meth, crack cocaine, opioids)
About this study
The current research will investigate the impact of general psychotherapy using common factors (i.e., techniques and communication skills that are common to all major forms of psychotherapy) to investigate whether mental health professionals can treat a variety of mental health concerns utilizing this general form of psychotherapy as opposed to specific forms of psychotherapy that may require specific trainings or education.
Read the detailed description
The current research will investigate the impact of general psychotherapy using common factors (i.e., techniques and communication skills that are common to all major forms of psychotherapy) to investigate whether mental health professionals can treat a variety of mental health concerns utilizing this general form of psychotherapy as opposed to specific forms of psychotherapy that may require specific trainings or education.
- Conditions
- Major Depression, Generalized Anxiety, Stress Disorder, Post Traumatic, Stress, Mental Disorders
- Being tested
- Common Factors Group Psychotherapy
- Keywords
- common factors psychotherapy
- Medical subject headings
- Depressive Disorder, Major, Generalized Anxiety Disorder, Stress Disorders, Post-Traumatic, Mental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Common Factors Group PsychotherapyBehavioural
This intervention will not contain active ingredients from established specific forms of psychotherapy (e.g., cognitive-behavioral therapy, dialectical behavioral therapy)
| Study group | Role | What they receive |
|---|---|---|
| Common Factors Group Therapy | Experimental | We will use a general common factors psychotherapy utilizing only psychotherapeutic techniques common to most forms of psychotherapy (e.g., listening and communication skills) Receives: Behavioral: Common Factors Group Psychotherapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Generalized Anxiety Disorder-7 Screener
Measure of anxiety symptoms. High scores more symptoms.
Measured: At enrollment and at the end of treatment at 6 weeks
Patient Health Questionnaire-9 Screener
Measure of depressive symptoms. High scores more symptoms.
Measured: At enrollment and at the end of treatment at 6 weeks
Patient Checklist-5
Measure of post-traumatic stress symptoms. High scores more symptoms.
Measured: At enrollment and at the end of treatment at 6 weeks
Yale-Brown Obsessive Compulsive Scale
Measure of obsessive compulsive disorder symptoms. High scores more symptoms.
Measured: At enrollment and at the end of treatment at 6 weeks
Alcohol Use Disorders Identification Test
Measure of concerning alcohol use. High scores more symptoms.
Measured: At enrollment and at the end of treatment at 6 weeks
National Institute of Drug Abuse Modified Alcohol, Smoking, and Substance Involvement Screening Test
Measure of substance use. High scores more use.
Measured: At enrollment and at the end of treatment at 6 weeks
Secondary outcomes (2)
Life Quality Scale
Measure of life quality. High scores better life quality.
Measured: At enrollment and at the end of treatment at 6 weeks
Experiential Avoidance Rating Scale
Measure of experiential avoidance. High scores more symptoms.
Measured: At enrollment and at the end of treatment at 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Sep 2024
- Study start17 Jan 2025
- Primary completion30 Dec 2025
- Study completion30 Dec 2025
Why it stopped: Inability for consistent recruitment.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Major DepressionStudies of the same condition, open and under way.
- More trials run by University of Alabama at BirminghamThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Alabama at Birmingham
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nicholas C. Borgogna, University of Alabama at Birmingham
- Investigators
- Nicholas Borgogna, PhD, Principal investigator, University of Alabama at BirminghamDrew Whittington, MS, MA, Principal investigator, University of Alabama at Birmingham
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06614842
- Sponsor's protocol ID
- IRB-300013539
- Other IDs
- UAB
- Status last verified
- Jun 2026
- First submitted
- 24 Sep 2024
- Last updated
- 18 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All de-identified data collected will be available2
Study at a glance
From the registry record, last updated by the sponsor on 18 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Common Factors Group Psychotherapy for General Mental Health Concerns
- ClinicalTrials.gov ID
- NCT06614842
- Acronym / sponsor ID
- IRB-300013539
- Conditions
- Major Depression, Generalized Anxiety, Stress Disorder, Post Traumatic, Stress, Mental Disorders
- Keywords
- common factors psychotherapy
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Inability for consistent recruitment.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- University of Alabama at BirminghamUniversity, hospital or other
- Study start
- 17 Jan 2025 (actual)
- Primary completion
- 30 Dec 2025 (actual)
- Study completion
- 30 Dec 2025 (actual)
- First posted
- 26 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The current research will investigate the impact of general psychotherapy using common factors (i.e., techniques and communication skills that are common to all major forms of psychotherapy) to investigate whether mental health professionals can treat a variety of mental health concerns utilizing this general form of psychotherapy as opposed to specific forms of psychotherapy that may require specific trainings or education.
Detailed description
The current research will investigate the impact of general psychotherapy using common factors (i.e., techniques and communication skills that are common to all major forms of psychotherapy) to investigate whether mental health professionals can treat a variety of mental health concerns utilizing this general form of psychotherapy as opposed to specific forms of psychotherapy that may require specific trainings or education.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Common Factors Group Therapy | Experimental | Behavioral: Common Factors Group PsychotherapyWe will use a general common factors psychotherapy utilizing only psychotherapeutic techniques common to most forms of psychotherapy (e.g., listening and communication skills) |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- At least 18 years old
- Experiencing self-reported psychological distress
Key exclusion criteria (6 listed)
- has engaged in self-harm within the last three months
- has attempted suicide within the last year
- has had an active plan to attempt suicide within the last 30 days
- currently diagnosed with any eating disorder
- has experienced hallucinations or delusions within the last 30 days
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Common Factors Group PsychotherapyThis intervention will not contain active ingredients from established specific forms of psychotherapy (e.g., cognitive-behavioral therapy, dialectical behavioral therapy) | Behavioural | Common Factors Group Therapy |
Primary outcome
Generalized Anxiety Disorder-7 Screener
Time frame: At enrollment and at the end of treatment at 6 weeks
Measure of anxiety symptoms. High scores more symptoms.
Patient Health Questionnaire-9 Screener
Time frame: At enrollment and at the end of treatment at 6 weeks
Measure of depressive symptoms. High scores more symptoms.
Patient Checklist-5
Time frame: At enrollment and at the end of treatment at 6 weeks
Measure of post-traumatic stress symptoms. High scores more symptoms.
Yale-Brown Obsessive Compulsive Scale
Time frame: At enrollment and at the end of treatment at 6 weeks
Measure of obsessive compulsive disorder symptoms. High scores more symptoms.
Alcohol Use Disorders Identification Test
Time frame: At enrollment and at the end of treatment at 6 weeks
Measure of concerning alcohol use. High scores more symptoms.
National Institute of Drug Abuse Modified Alcohol, Smoking, and Substance Involvement Screening Test
Time frame: At enrollment and at the end of treatment at 6 weeks
Measure of substance use. High scores more use.
2 secondary outcomes
Life Quality Scale
Time frame: At enrollment and at the end of treatment at 6 weeks
Experiential Avoidance Rating Scale
Time frame: At enrollment and at the end of treatment at 6 weeks
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jun 2026.
- Individual participant dataSharing planned: Yes. All de-identified data collected will be available2
Related trials for Major Depression
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
RecruitingPhase 4
Biomarker-Guided Antidepressant Selection
Depression - Major Depressive Disorder, Treatment-resistant Depression (TRD)
Recruiting
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
Major Depressive Disorder, Apathy
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
Acute Intermittent Hypoxia Therapy for Depression
Major Depressive Disorder (MDD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nicholas Borgogna, PhD principal investigator
University of Alabama at Birmingham
Drew Whittington, MS, MA principal investigator
University of Alabama at Birmingham
Questions about this trial
What is this clinical trial studying?
A study testing Common Factors Group Psychotherapy in people with Major Depression and Generalized Anxiety, run by University of Alabama at Birmingham.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 18 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Generalized Anxiety Disorder-7 Screener (time frame: At enrollment and at the end of treatment at 6 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2026.